This is a Brand Name Only requirement

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

ARMY MED RES ACQ ACTIVITY

Contract Value

Not provided

Codes & Classification
Solicitation Number

HT942525R0057

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing

Classification Code

6640

Additional Details
Set Aside

None

Place of Performance

Dover, Delaware, UNITED STATES

SourceSAM
The Army Medical Research Acquisition Activity (AMRAA), a federal office, has issued an award notice for a Brand Name Only Blanket Purchase Agreement under procurement identifier HT942525R0057. This procurement is classified under NAICS Code 325413, which pertains to In-Vitro Diagnostic Substance Manufacturing, and is further designated by Product Service Code 6640. The place of performance for this agreement is Dover, Delaware, United States. The purpose of this procurement is to establish a blanket purchase agreement for specific brand name in-vitro diagnostic substances. By specifying "Brand Name Only," the contracting entity requires products that meet precise standards and specifications associated with a particular manufacturer or brand, ensuring consistency and reliability in diagnostic applications. This approach is typically adopted to maintain compatibility with existing equipment, uphold validated laboratory protocols, or meet regulatory requirements. The scope of the agreement encompasses the supply of in-vitro diagnostic substances, which are essential for medical research, clinical testing, and related laboratory activities. The intended outcome is to secure a reliable source of these specialized products, supporting the operational needs of the Army’s medical research and healthcare initiatives in Dover, Delaware. Key requirements for contractors include the ability to provide the exact brand name products specified in the agreement, in compliance with the standards outlined for in-vitro diagnostic substance manufacturing. Deliverables are expected to be consistent with the quality and performance characteristics of the designated brand, ensuring that all supplied items meet the stringent requirements of the Army Medical Research Acquisition Activity. As this is an award notice, the opportunity is no longer active, and the agreement has already been executed. Contractors interested in similar future opportunities should note the following constant elements: the contracting entity is the Army Medical Research Acquisition Activity, the place of performance is Dover, Delaware, and the procurement will likely continue to focus on in-vitro diagnostic substances under NAICS 325413 and PSC 6640. For reference or future engagement, the primary point of contact is Kasey Carroll ([email protected], 301-619-2799), and the secondary contact is Courtney Piar ([email protected], 240-367-2228). Additional details and updates can be found on the official SAM.gov opportunity page at https://sam.gov/opp/cd0f748449584bd0acf18fe5305e5698/view. This procurement did not specify any set-aside requirements or special considerations beyond the brand name restriction. Contractors with capabilities in manufacturing or supplying in-vitro diagnostic substances of the specified brand may find similar future opportunities aligned with their expertise and product offerings.